@article{TCR8031,
author = {Hui K. Gan and Antony W. Burgess and Adam C. Parslow and Andrew M. Scott},
title = {Dual targeting of EGFR: ready for prime time?},
journal = {Translational Cancer Research},
volume = {5},
number = {Suppl 1},
year = {2016},
keywords = {},
abstract = {Monoclonal antibodies against the Epidermal Growth Factor Receptor (EGFR) are accepted therapies in number of cancer types including colorectal cancer (CRC), and head and neck cancer.},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/8031}
}